Methods for genetic analysis of DNA to detect sequence variances

• US 8,129,120 B2
• Filed: 02/28/2007
• Issued: 03/06/2012
• Est. Priority Date: 05/23/2000
• Status: Expired due to Fees

• Current Assignee: Agena Bioscience Inc. (Mesa Laboratories Inc.)
• Original Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Inventors: Olson, Jeffrey, Zillmann, Martin, Stanton, Vincent P. Jr.
• Primary Examiner(s): Chunduru, Prabha
• Application Number:
  US11/680,447
• Publication Number:
  US 20080206748A1
• Time in Patent Office: 1,833 Days
• Field of Search: 435/6, 435/91.2, 536/24.33
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers

Abstract

Methods for determining genotypes and haplotypes of genes are described. Also described are single nucleotide polymorphisms and haplotypes in the ApoE gene and methods of using that information.

Claims

1. A method for determining the nucleotide present at a selected polymorphic site in a target nucleic acid molecule, the method comprising:

a) amplifying a portion of the target nucleic acid molecule comprising the selected polymorphic site using a first primer and a second primer, the second primer containing a recognition site for a first restriction enzyme and a recognition site for a second restriction enzyme, to generate amplification product containing a recognition site for the first restriction enzyme and a recognition site for the second restriction enzyme such that digestion of the amplification product with the first restriction enzyme and the second restriction enzyme generates a nucleic acid fragment containing the selected polymorphic site;

b) digesting the amplification product with the first restriction enzyme and the second restriction enzyme to generate a nucleic acid fragment containing the selected polymorphic site within a 5′

single-stranded overhang;

c) filling the recessed end corresponding to the 5′

overhang with nucleotides wherein at least one of the nucleotides is bromodeoxuridine; and

d) analyzing the nucleic acid fragment to identify the nucleotide present at the selected polymorphic site.

2. The method of claim 1 wherein the second primer comprises at least one nucleotide sequence that is not present in the target nucleic acid molecule.

3. The method of claim 2 wherein the second primer comprises 5′

nucleotide sequence that is complementary to a first portion of the target nucleic acid molecule, a 3′

nucleotide sequence that is complementary to a second portion of the target nucleic acid molecule, and a nucleotide sequence that is not complementary to the target nucleic acid molecule.

4. The method of claim 1 wherein the first restriction enzyme is a type IIS restriction enzyme.

5. The method of claim 1 wherein the step of analyzing the nucleic acid fragment to identify the nucleotide present at the selected polymorphic site comprises subjecting the nucleic acid fragment to mass spectrometry.